Your browser doesn't support javascript.
loading
Association of DNA methylation signatures with cognitive performance among smokers and ex-smokers.
Hsu, Ping-Ching; Daughters, Stacey B; Bauer, Michael A; Su, L Joseph; Addicott, Merideth A.
Afiliação
  • Hsu PC; Department of Environmental Health Sciences, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, United States.
  • Daughters SB; Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, United States.
  • Bauer MA; Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, United States.
  • Su LJ; Peter O'Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, United States.
  • Addicott MA; Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, United States.
Tob Induc Dis ; 21: 106, 2023.
Article em En | MEDLINE | ID: mdl-37605769
ABSTRACT

INTRODUCTION:

Alterations in DNA methylation profiles have been associated with cancer, and can be influenced by environmental factors such as smoking. A small but growing literature indicates there are reproducible and robust differences in methylation levels among smokers, never smokers, and ex-smokers. Here, we compared differences in salivary DNA methylation levels among current and ex-smokers (at least 2 years abstinent).

METHODS:

Smokers (n=26) and ex-smokers (n=30) provided detailed smoking histories, completed the Paced Auditory Serial Addition Test (PASAT), and submitted a saliva sample. Whole-genome DNA methylation from saliva was performed, and ANCOVA models and a receiver operating characteristic (ROC) curve were used for the differences between groups and the performance of significant CpG sites.

RESULTS:

After controlling for race, age, and gender, smokers had significantly lower methylation levels than ex-smokers in two CpG sites cg05575921 (AHRR) and cg21566642 (ALPPL2). Based on the ROC analyses, both CpGs had strong classification potentials (cg05575921 AUC=0.97 and cg21566642 AUC=0.93) in differentiating smoking status. Across all subjects, the percent methylation of cg05575921 (AHRR) and cg21566642 (ALPPL2) positively correlated with the length of the last quit attempt (r=0.65 and 0.64, respectively, p<0.001) and PASAT accuracy (r=0.29 and 0.30, respectively, p<0.05).

CONCLUSIONS:

In spite of the small sample size and preliminary research, our results replicate previously reported differences in AHRR hypomethylation among smokers. Furthermore, we show that the duration of smoking abstinence is associated with a recovery of methylation in ex-smokers, which may be linked to a reduced risk of smoking-associated diseases. The association with cognitive performance suggests that the hypomethylation of AHRR in saliva may reflect systemic exposure to cigarette-related toxicants that negatively affect cognitive performance, and should be validated in larger studies.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Tob Induc Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Tob Induc Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos